Anti-Ovalbumin antibody

• WB

Supplier Data

Western blot - Anti-Ovalbumin antibody (AB181688)

Lane 1 + 2 under reducing conditions; Lane 3 + 4 under non-reducing conditions.

All lanes:

Western blot - Anti-Ovalbumin antibody (ab181688) at 1/5000 dilution

Lanes 1 and 3:

Ovalbumin protein at 1 µg

Lanes 2 and 4:

Ovalbumin protein at 0.25 µg

Secondary

All lanes:

Atto 425 conjugated goat anti rabbit secondary antibody at 1/10000 dilution

Observed band size: 36 kDa

false

• WB

Supplier Data

Western blot - Anti-Ovalbumin antibody (AB181688)

All lanes:

Western blot - Anti-Ovalbumin antibody (ab181688) at 1/1000 dilution

All lanes:

Reduced Ovalbumin at 0.005 µg

Secondary

All lanes:

Peroxidase rabbit secondary antibody 30 min at RT at 1/40000 dilution

Observed band size: 45 kDa

false

• IHC

CiteAb

Immunohistochemistry - Anti-Ovalbumin antibody (AB181688)

Ovalbumin immunohistochemistry using Anti-Ovalbumin antibody ab181688. Publication image and figure legend from Zeng, Z., Gao, J., et al., 2023, Int J Biol Sci, Pubmed 37416767.

NADK promotes the lymph node metastasis of NSCLC cells. Figure 3A. The schematic illustration of LN metastasis model preformed on C57BL/6 mice. 3B. LN metastasis model was conducted on C57BL/6 mice with LLC-NADK overexpression cells, popliteal lymph nodes were isolated at the end of the experiment, and LN volume was measured and analysed. 3C. IHC staining and HE staining were performed on lymph node tissues in 3B with anti-Ovalbumin antibody. Ovalbumin positive cells were counted and analysed. Figure 3D. LN metastasis model was performed on C57BL/6J mice using LLC cells with knockdown of NADK. Popliteal lymph nodes were isolated at the end of the experiment, and LN volume was measured and analysed. 3E. Lymph node tissues in 3D were examined using IHC staining with anti-Ovalbumin antibody or H&E staining. Cells expressing Ovalbumin were counted and analysed. The scale bars were indicated. **, P<0.01.